Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol. (2020)
Attributed to:
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3399/bjgpopen20x101115
PubMed Identifier: 32665234
Publication URI: http://europepmc.org/abstract/MED/32665234
Type: Journal Article/Review
Volume: 4
Parent Publication: BJGP open
Issue: 3
ISSN: 2398-3795